Cancer Proteomics

Proteomics based techniques allow the description of biomarkers and protein expression signatures, which are used to anticipate responses to drugs and the clinical course of disease, and such advice could be used to analyze therapy. Indeed, proteomics and imaging technologies are being associated to advance diagnostics, histological grading of tumours and responses to therapy. Such breakthrough is integrated by huge number of clinical samples being accumulate in biobanks, which allows researchers to screen large cohorts and approve their findings.

Relevant Conferences:

Conference on Pancreatic & Colorectal Cancer during March 29-30, 2016 Atlanta, USA; 2nd International Conference on Prostate Cancer & Treatment during May 05-07, 2016 Chicago, USA; Cancer Diagnostics Conference and Exhibition during June 13-15, 2016 Rome, Italy; Conference on Cancer Immunology & Immunotherapy during July 28-30, 2016 Melbourne, Australia; Conference on Thyroid Cancer & Treatment during August 01-03, 2016 Toronto, Canada; European Lung Cancer Conference during April 13-16, 2016 Geneva, Switzerland; Breast Cancer Conference during May 12-14, 2016 Brussels, Belgium; World Congress on Gastrointestinal Cancer 2016 during June 29-July 02, 2016 Barcelona, Spain; Symposium on Immuno Oncology 2016 during November 04-05, 2016 Lausanne, Switzerland.

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Proteomic technologies hold recently great promise in the search of new clinical biomarkers for the early detection and diagnosis of cancer as well as the discovery of new therapeutic targets from accessible bio-specimens. Cancer systems biology encompasses the application of systems biology approaches to cancer research, in order to study the disease as a complex adaptive system with emerging properties at multiple biological scales.

  • Cancer biomarker discovery
  • Proteomics in cancer diagnosis
  • Quantitative proteomics in cancer systems biology

Related Conference of Cancer Proteomics

(6 Plenary Forums, 3 Days, 1 Event)
October 03-05, 2016

2nd International Conference and Expo on Lipids: Metabolism, Nutrition & Health

Orlando, Florida, USA
October 10-12, 2016

International Conference on Biochemistry

Kuala Lumpur, Malaysia
October 24-26, 2016

7th International Conference and Expo on Proteomics

Rome, Italy
October 24-25, 2016

7th International Conference on Bioinformatics

Rome, Italy
November 14-16, 2016

2nd International Conference on Genetic and Protein Engineering

Atlanta, Georgia, USA
November 14-16, 2016

7th International Conference and Expo on Metabolomics

Orlando, Florida, USA
December 08-09, 2016

Global Congress on Biochemistry, Glycomics and Amino Acids

San Antonio, TX, USA
(5 Plenary Forums-1 Event)
Dec 8-9 2016

Global Congress on Biochemistry, Glycomics and Amino Acids

San Antonio, TX, USA
December 08-09, 2016

Global Congress on Biochemistry, Glycomics and Amino Acids

San Antonio, Texas, USA
March 20-21, 2017

International Conference on Enzymology

Rome, Italy
June 26-28, 2017

3rd Glycobiology World Congress

London, UK
August 31-September 01, 2017

2nd Global Congress on Nucleic Acids: Biology, Health & Diseases

Philadelphia, Pennsylvania, USA
September 18-19, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand

Cancer Proteomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in